Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2008 1
2009 1
2012 1
2013 3
2016 2
2017 4
2018 2
2019 2
2020 5
2021 6
2022 5
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma.
Tripodi L, Feola S, Granata I, Whalley T, Passariello M, Capasso C, Coluccino L, Vitale M, Scalia G, Gentile L, De Lorenzo C, Guarracino MR, Castaldo G, D'Argenio V, Szomolay B, Cerullo V, Pastore L. Tripodi L, et al. Among authors: scalia g. iScience. 2023 Aug 19;26(10):107668. doi: 10.1016/j.isci.2023.107668. eCollection 2023 Oct 20. iScience. 2023. PMID: 37720092 Free PMC article.
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response.
Cernera G, Gelzo M, De Placido P, Ottaviano M, Pietroluongo E, Raia M, Scalia G, Tortora M, Castaldo G, Formisano P, Palmieri G, Giuliano M. Cernera G, et al. Among authors: scalia g. Front Immunol. 2023 Aug 29;14:1233056. doi: 10.3389/fimmu.2023.1233056. eCollection 2023. Front Immunol. 2023. PMID: 37705978 Free PMC article.
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia.
Battipaglia G, Vincenzi A, Falconi G, Fiore A, D'Agostino F, Iannotta R, Grimaldi F, Gurnari C, Galossi E, Crisà E, Bonello F, Scalia G, Izzo B, Voso MT, Pane F. Battipaglia G, et al. Among authors: scalia g. Curr Res Transl Med. 2023 Apr-Jun;71(2):103386. doi: 10.1016/j.retram.2023.103386. Epub 2023 Feb 26. Curr Res Transl Med. 2023. PMID: 36905702 No abstract available.
MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity.
Gelzo M, Castaldo A, Giannattasio A, Scalia G, Raia M, Esposito MV, Maglione M, Muzzica S, D'Anna C, Grieco M, Tipo V, La Cava A, Castaldo G. Gelzo M, et al. Among authors: scalia g. Front Immunol. 2022 Oct 3;13:985433. doi: 10.3389/fimmu.2022.985433. eCollection 2022. Front Immunol. 2022. PMID: 36263058 Free PMC article.
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis.
Capasso N, Nozzolillo A, Scalia G, Lanzillo R, Carotenuto A, De Angelis M, Petruzzo M, Saccà F, Russo CV, Brescia Morra V, Moccia M. Capasso N, et al. Among authors: scalia g. Mult Scler Relat Disord. 2021 Apr;49:102802. doi: 10.1016/j.msard.2021.102802. Epub 2021 Jan 28. Mult Scler Relat Disord. 2021. PMID: 33556652
Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis.
Spiezia AL, Cerbone V, Molinari EA, Capasso N, Lanzillo R, Carotenuto A, Petracca M, Novarella F, Covelli B, Scalia G, Brescia Morra V, Moccia M. Spiezia AL, et al. Among authors: scalia g. Mult Scler Relat Disord. 2022 Jan;57:103431. doi: 10.1016/j.msard.2021.103431. Epub 2021 Nov 29. Mult Scler Relat Disord. 2022. PMID: 34871857 No abstract available.
37 results